NeoGenomics (NEO)
NASDAQ:NEO
Holding NEO?
Track your performance easily

NeoGenomics (NEO) Technical Analysis

1,786 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
NeoGenomics’s (NEO) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting NeoGenomics is a Sell.
NeoGenomics’s (NEO) 20-Day exponential moving average is 13.86, while NeoGenomics’s (NEO) share price is $15.46, making it a Buy.
NeoGenomics’s (NEO) 50-Day exponential moving average is 14.37, while NeoGenomics’s (NEO) share price is $15.46, making it a Buy.

NeoGenomics (NEO) Pivot Points

Nov 07, 2024, 01:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.68
13.79
13.97
14.08
14.26
14.37
14.55
Fibonacci
13.79
13.90
13.97
14.08
14.19
14.26
14.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NeoGenomics (NEO) Moving Averages

Nov 07, 2024, 01:30 AM
Period
Simple
Exponential
MA5
14.03Buy
14.18Buy
MA10
13.63Buy
13.89Buy
MA20
13.57Buy
13.86Buy
MA50
14.72Buy
14.37Buy
MA100
14.89Buy
14.75Buy
MA200
14.85Buy
15.20Sell
NeoGenomics’s (NEO) 10-Day exponential moving average is 13.89, while NeoGenomics’s (NEO) share price is $15.46, making it a Buy.
NeoGenomics’s (NEO) 100-Day exponential moving average is 14.75, while NeoGenomics’s (NEO) share price is $15.46, making it a Buy.
NeoGenomics’s (NEO) stock price is $15.46 and NeoGenomics’s (NEO) 50-day simple moving average is 14.72, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $15.46 and NeoGenomics’s (NEO) 100-day simple moving average is 14.89, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $15.46 and NeoGenomics’s (NEO) 200-day simple moving average is 14.85, creating a Buy signal.

NeoGenomics (NEO) Technical Indicators

Nov 07, 2024, 01:30 AM
Name
Value
Implied Action
RSI (14)
63.78
Neutral
STOCH (9,6)
85.93
Sell
STOCHRSI (14)
86.05
Sell
MACD (12,26)
-0.12
Sell
ADX (14)
30.80
Neutral
Williams %R
-6.73
Sell
CCI (14)
212.58
Sell
ATR (14)
0.57
-
Ultimate Oscillator
66.43
Neutral
ROC
7.95
Buy
NeoGenomics’s (NEO) Relative Strength Index (RSI) is 63.78, creating a Neutral signal.
NeoGenomics’s (NEO) Trend Strength Indicator (ADX) is 30.80, creating a Neutral signal.
NeoGenomics’s (NEO) Commodity Channel Index (CCI) is 212.58, creating a Sell signal.
NeoGenomics’s (NEO) Price Rate of Change (ROC) is 7.95, creating a Buy signal.

FAQ

Is NEO a Buy, Hold, or Sell?
Based on NEO’s technical indicators, NEO is a Buy.
    What is NEO’s RSI (14)?
    NEO’s RSI (14) is 63.78, which suggests NEO is a Neutral.
      What is NEO’s MACD?
      NEO’s MACD is -0.12, which suggests NEO is a Sell.
        What is NEO’s 5-day moving average?
        NEO’s 5-day moving average is 14.03, which suggests NEO is a Buy.
          What is NEO’s 20-day moving average?
          NEO 20-day moving average is 13.57, which suggests NEO is a Buy.
            What is NEO’s 50-day moving average?
            NEO’s 50-day moving average is 14.72, which suggests NEO is a Buy.
              What is NEO’s 200-day moving average?
              NEO’s 200-day moving average is 14.85, which suggests NEO is a Buy.
                What is NEO’s Williams % R (14)?
                NEO’s Williams % R (14) is -6.73, which suggests NEO is a Sell.
                  What is NEO’s CCI (14)?
                  NEO’s CCI (14) is 212.58, which suggests NEO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis